Filing excerpt
We anticipate maintaining substantial expenses across all areas of our ongoing activities, particularly as we continue research and development of our development candidates and clinical activities for our investigational medicines. This also extends to our manufacturing costs, including our arrangements with our supply and manufacturing partners. Our ongoing work on our... late-stage clinical development, investments in digital capabilities and artificial intelligence technologies... will require significant cash outflows in future periods...